These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Antipsychotic-withdrawal akathisia versus antipsychotic-induced akathisia: further evidence for the existence of tardive akathisia. Dufresne RL; Wagner RL J Clin Psychiatry; 1988 Nov; 49(11):435-8. PubMed ID: 2903141 [TBL] [Abstract][Full Text] [Related]
3. The Hillside Akathisia Scale: a new rating instrument for neuroleptic-induced akathisia. Fleischhacker WW; Bergmann KJ; Perovich R; Pestreich LK; Borenstein M; Lieberman JA; Kane JM Psychopharmacol Bull; 1989; 25(2):222-6. PubMed ID: 2574895 [No Abstract] [Full Text] [Related]
4. Akathisia: a distressing complication of neuroleptic treatment. Szabadi E Compr Ther; 1987 Sep; 13(9):3-6. PubMed ID: 2889560 [No Abstract] [Full Text] [Related]
5. Opioid responsiveness in patients with neuroleptic-induced akathisia. Walters A; Hening W; Chokroverty S; Fahn S Mov Disord; 1986; 1(2):119-27. PubMed ID: 2904116 [TBL] [Abstract][Full Text] [Related]
6. Propranolol in the treatment of tardive akathisia: a report of two cases. Yassa R; Iskandar H; Nastase C J Clin Psychopharmacol; 1988 Aug; 8(4):283-5. PubMed ID: 2905362 [TBL] [Abstract][Full Text] [Related]
8. Relationship between neuroleptic extrapyramidal syndromes and patients' all-cause mortality. Modestin J; Vogt Wehrli M; Stephan PL; Agarwalla P Pharmacopsychiatry; 2009 Mar; 42(2):57-60. PubMed ID: 19308879 [TBL] [Abstract][Full Text] [Related]
9. Identifying akinesia and akathisia: the relationship between patient's self-report and nurse's assessment. Michaels RA; Mumford K Arch Psychiatr Nurs; 1989 Apr; 3(2):97-101. PubMed ID: 2565706 [TBL] [Abstract][Full Text] [Related]
10. Propranolol as a primary treatment of neuroleptic-induced akathisia. Irwin M; Sullivan G; Van Putten T Hillside J Clin Psychiatry; 1988; 10(2):244-50. PubMed ID: 2906317 [TBL] [Abstract][Full Text] [Related]
11. Tardive akathisia: an analysis of clinical features and response to open therapeutic trials. Burke RE; Kang UJ; Jankovic J; Miller LG; Fahn S Mov Disord; 1989; 4(2):157-75. PubMed ID: 2567492 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of low-dose metoprolol in neuroleptic-induced akathisia. Kim A; Adler L; Angrist B; Rotrosen J J Clin Psychopharmacol; 1989 Aug; 9(4):294-6. PubMed ID: 2570088 [TBL] [Abstract][Full Text] [Related]
13. [Akathisia--diagnosis, pathophysiology and therapy]. Zyss T; Banach M; Zieba A Psychiatr Pol; 2009; 43(4):387-402. PubMed ID: 20128247 [TBL] [Abstract][Full Text] [Related]
14. [Propranolol in the treatment of neuroleptic-induced akathisia]. Wang HL Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1988 Oct; 21(5):303-5, 320. PubMed ID: 2906858 [No Abstract] [Full Text] [Related]
15. Studies on the time course and efficacy of beta-blockers in neuroleptic-induced akathisia and the akathisia of idiopathic Parkinson's disease. Adler LA; Angrist B; Weinreb H; Rotrosen J Psychopharmacol Bull; 1991; 27(2):107-11. PubMed ID: 1681561 [TBL] [Abstract][Full Text] [Related]
17. Treatment of neuroleptic induced akathisia with the 5-HT2 antagonist ritanserin. Miller CH; Fleischhacker WW; Ehrmann H; Kane JM Psychopharmacol Bull; 1990; 26(3):373-6. PubMed ID: 1980375 [TBL] [Abstract][Full Text] [Related]
18. Neuroleptic-induced akathisia treated with pindolol. Reiter S; Adler L; Erle S; Duncan E Am J Psychiatry; 1987 Mar; 144(3):383-4. PubMed ID: 2881493 [No Abstract] [Full Text] [Related]